Our previous study showed that β2M protein expression is positively associated with ER expression and is not associated with HER2 in breast cancer, and β2M has different regulatory effects on the expression of Bcl-2 and HER2 between ER+ and ER− breast cancer cells with HER2− [3]. This evidence concerns the gene BCL2 and breast cancer.